Studies have shown that the ANGPTL4 level of serum was significantly elevated in COPD patients (42), and the overexpression of ANGPTL4 was associated with lung function and inflammation (43). This evidence concerns the gene ANGPTL4 and chronic obstructive pulmonary disease.